Follow
Sixten Borg
Sixten Borg
Ph D, Regional Cancer Centre South, Lund, Sweden
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark
T Jess, L Riis, I Vind, KV Winther, S Borg, V Binder, E Langholz, ...
Inflammatory bowel diseases 13 (4), 481-489, 2006
4952006
The costs of exacerbations in chronic obstructive pulmonary disease (COPD)
F Andersson, S Borg, SA Jansson, AC Jonsson, ÅSA ERICSSON, C Prütz, ...
Respiratory medicine 96 (9), 700-708, 2002
3682002
Costs of COPD in Sweden according to disease severity
SA Jansson, F Andersson, S Borg, Å Ericsson, E Jönsson, B Lundbäck
Chest 122 (6), 1994-2002, 2002
2722002
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease
S Borg, Å Ericsson, J Wedzicha, A Gulsvik, B Lundbäck, GC Donaldson, ...
Value in Health 7 (2), 153-167, 2004
1162004
Obesity, survival, and hospital costs—findings from a screening project in Sweden
S Borg, U Persson, K Ödegaard, G Berglund, JÅ Nilsson, PM Nilsson
Value in Health 8 (5), 562-571, 2005
1072005
Costs and quality of life in multiple sclerosis patients with spasticity
J Svensson, S Borg, P Nilsson
Acta neurologica Scandinavica 129 (1), 13-20, 2014
802014
Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes–a nationwide cross-sectional study
M Svedbo Engström, J Leksell, UB Johansson, S Borg, B Palaszewski, ...
Health and quality of life outcomes 17, 1-11, 2019
772019
Drug and treatment costs in Parkinson’s disease patients in Sweden
J Lökk, S Borg, J Svensson, U Persson, G Ljunggren
Acta Neurologica Scandinavica 125 (2), 142-147, 2012
632012
Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources
M Hoogendoorn, TL Feenstra, M Boland, AH Briggs, S Borg, SA Jansson, ...
International journal of chronic obstructive pulmonary disease 12, 3183, 2017
552017
The impact of exacerbations on the asthmatic patient's preference scores
F Andersson, S Borg, E Ståhl
Journal of Asthma 40 (6), 615-623, 2003
522003
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios
M Hoogendoorn, TL Feenstra, Y Asukai, S Borg, RN Hansen, SA Jansson, ...
Value in Health 17 (5), 525-536, 2014
502014
The Swedish cost burden of overweight and obesity–evaluated with the PAR approach and a statistical modelling approach
K Odegaard, S Borg, U Persson, M Svensson
International Journal of Pediatric Obesity 3 (sup1), 51-57, 2008
492008
A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content …
MS Engström, J Leksell, UB Johansson, K Eeg-Olofsson, S Borg, ...
Patient education and counseling 101 (1), 139-146, 2018
432018
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden
T Hofmarcher, S Borg
Journal of medical economics 18 (7), 492-501, 2015
332015
Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months.
L Rosenhall, S Borg, F Andersson, K Ericsson
International journal of clinical practice 57 (8), 662-667, 2003
322003
Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and …
S Borg, K Eeg-Olofsson, B Palaszewski, MS Engström, UG Gerdtham, ...
BMJ open 9 (1), e025033, 2019
292019
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort
UG Gerdtham, LF Andersson, Å Ericsson, S Borg, SA Jansson, ...
The European Journal of Health Economics 10 (2), 217-226, 2009
292009
Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden
S Borg, B Palaszewski, UG Gerdtham, Ö Fredrik, P Roos, ...
International journal of environmental research and public health 11 (12 …, 2014
242014
Cost differences for COPD with and without physician-diagnosis
SA Jansson, A Lindberg, Å Ericsson, S Borg, E Rönmark, F Andersson, ...
COPD: Journal of Chronic Obstructive Pulmonary Disease 2 (4), 427-434, 2005
242005
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
S Borg, H Nahi, M Hansson, D Lee, J Elvidge, U Persson
Acta Oncologica 55 (5), 554-560, 2016
222016
The system can't perform the operation now. Try again later.
Articles 1–20